Skip to main content

Sara Isabel Reidel

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Sara Isabel Reidel

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Integración de datos del mundo real, de salud y de investigación para la mejora de los protocolos clínicos en la enfermedad falciforme y otras anemias raras

IP: M Mar Mañu Pereira
Collaborators: Sara Isabel Reidel , David Beneitez Pastor, Maria Cristina Díaz de Heredia Rubio, Adoración Blanco Alvarez
Funding agency: Instituto de Salud Carlos III
Funding: 152500
Reference: PI24/00477
Duration: 01/01/2025 - 31/12/2027

ERDERA: European Rare Disease Research Alliance

IP: M Mar Mañu Pereira
Collaborators: Augusto Cesar Sao Aviles, Patricia González Ruiz, Claire Diot, Miguel Chillon Rodriguez, Simon Schwartz Navarro, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 1252083.33
Reference: ERDERA/EC/HLTH-2023-DISEASE-07-01/2023/MAÑU
Duration: 01/09/2024 - 31/08/2031

ERN-EuroBloodNet (European Reference Network on Rare Hematological Diseases)

IP: M Mar Mañu Pereira
Collaborators: Raquel Mosull del Campo, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 1569581.5
Reference: EUROBLOODNET-ERN_EU4H2023
Duration: 01/10/2023 - 30/09/2027

ERN-EuroBloodNet: EUROPEAN REFERENCE NETWORK ON RARE HEMATOLOGICAL DISEASES

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, Claire Diot, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 371825
Reference: EUROBLOODNETBR2022_EU4H-ERN2022
Duration: 01/05/2022 - 30/11/2023

Related news

The European initiative Hope4Kids will strengthen and harmonise paediatric palliative care across Europe, with the aim of ensuring comprehensive, high-quality care for all children living with life-threatening or life-limiting conditions.

The initiative will enable young people aged 12 to 18 to collaborate with campus researchers in the design, development and communication of scientific projects, placing patients and families at the centre of the research process.

The REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up.

Related professionals

Claudia Serra Masmitja

Claudia Serra Masmitja

Predoctoral researcher
Multidisciplinary Nursing Research Group
Read more
Raquel Adeliño Recasens

Raquel Adeliño Recasens

Predoctoral researcher
Cardiovascular Diseases
Read more
Ana Maria Ciscar Bellés

Ana Maria Ciscar Bellés

Postdoctoral researcher
General Surgery
Read more
Clara Bordes Garcia

Clara Bordes Garcia

Predoctoral researcher
Maternal and Fetal Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.